To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic
NCT04412239 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2020-11-18
Summary
The COVID-19 pandemic might be an opportunity to review and refine our practices in anti TB treatment. For the follow-up of selected patients, telephone consultations may be efficient and cost-effective. The aim of the study is to assess the efficiency and the satisfaction with telephone consultation for the pharmacist and the TB patient. The study was conducted in tertiary care hospital TB control centres patients.
Conditions
- TB - Tuberculosis
- Patient Satisfaction
Interventions
- BEHAVIORAL
-
Patient-centred advice on Telephone Consultation in TB Patients:
The primary aim was to assess the efficiency and the satisfaction of the telephone consultation. The COVID-19 pandemic might be an opportunity to review and refine our practices in TB care. For the follow-up of selected patients, telephone consultations may be efficient and cost effective.
Sponsors & Collaborators
-
Pakistan Institute of Medical Sciences
collaborator OTHER_GOV -
District Headquarter Hospital Bannu Pakistan
collaborator UNKNOWN -
Xi'an Jiaotong University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-20
- Primary Completion
- 2020-12-20
- Completion
- 2020-12-20
Countries
- Pakistan
Study Locations
More Related Trials
-
Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
NCT05280886 ·Status: UNKNOWN
-
Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis
NCT03827811 ·Status: UNKNOWN
-
The Effect of Telephone Follow-up and Training on Treatment Adherence in Tuberculosis Patients and Contacts
NCT05202431 ·Status: COMPLETED ·Phase: NA
-
Effect of Community Mobile Outreach Approach Compared to Facility Based Directly Observed Treatment Short Course on Treatment Outcome Among Tuberculosis Patients in Jeddah: A Randomized Controlled Trial
NCT03787914 ·Status: COMPLETED ·Phase: NA
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)
NCT06883643 ·Status: COMPLETED ·Phase: NA
-
Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
NCT05454345 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru
NCT01201941 ·Status: COMPLETED
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs
NCT00979290 ·Status: COMPLETED
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB
NCT06526039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis
NCT02313610 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment
NCT02810678 ·Status: COMPLETED ·Phase: NA
-
Impact of Mobile Health Interactive Software on Tuberculosis Outcomes; The Call for Life (CFLU-TB) Project
NCT04709159 ·Status: UNKNOWN ·Phase: NA
-
A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)
NCT03563599 ·Status: COMPLETED ·Phase: PHASE2
-
Latency in Pulmonary Tuberculosis
NCT01154959 ·Status: COMPLETED ·Phase: PHASE3
-
The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB)
NCT02953847 ·Status: COMPLETED ·Phase: PHASE1
-
The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study
NCT01182259 ·Status: UNKNOWN
-
Acute Presentation and Management of Abdominal Tuberculosis: A Ten-year Experience at a Tertiary Care Center in Pakistan
NCT03918226 ·Status: COMPLETED ·Phase: NA
-
Ultra-Short Regimen for Elderly DS-TB
NCT07076225 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study on the Management Model of "Home Treatment" for Tuberculosis Patients
NCT03967353 ·Status: UNKNOWN ·Phase: NA
-
Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
NCT03312647 ·Status: UNKNOWN
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants
NCT04472897 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02288481 ·Status: COMPLETED ·Phase: PHASE1